Search results
Wells Fargo maintains Overweight rating on Neurocrine Bio shares By Investing.com
Investing.com· 3 days agoThe firm's endorsement follows the presentation of updated data on Neurocrine's drug candidate...
Massive Bio partners with Mika Health to expand oncology app
Medical Device Network via Yahoo Finance· 5 days agoThe partnership will see patients provided with free access to Mika Health’s software designed to...
High levels of novel biomarker GDF15 in steatotic liver patients linked to increased liver cancer...
Medical Xpress· 2 days agoThe findings are published in the journal Alimentary Pharmacology & Therapeutics. Steatotic (fatty) liver disease is on the rise in many countries around the world. A rise in steatotic liver ...
Personalized flu shots closer after major breakthrough | FOX 28 Spokane
FOX 28 Spokane· 5 days agoPersonalized flu jabs are a major step nearer following a significant breakthrough. Researchers have...
Diet-induced inflammation positively tied to marker of heart failure
Medical Xpress· 2 days agoThere is a positive correlation between diet-induced inflammation and a heart failure biomarker,...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 3 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
You Don't Need to Obsess Over Frequent Blood Tests to Get Healthier and Live Longer
GQ via Yahoo News· 4 days agoWhile the program, called EQX Optimize, is brand new, the announcement was just the latest...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 5 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
High Rate of Surgery in Patients With Crohn's Disease
Medscape· 6 days agoScientific data indicate that the chance of a patient with Crohn's disease undergoing intestinal...
Immunotherapy significantly increases the number of patients free from bowel cancer: Clinical trial
Medical Xpress· 6 days agoThe findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024, are...